1. Home
  2. SRI vs RNA Comparison

SRI vs RNA Comparison

Compare SRI & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$7.22

Market Cap

205.4M

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$10.51

Market Cap

222.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
RNA
Founded
1965
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.4M
222.5M
IPO Year
1997
2025

Fundamental Metrics

Financial Performance
Metric
SRI
RNA
Price
$7.22
$10.51
Analyst Decision
Buy
Buy
Analyst Count
1
20
Target Price
$16.00
$69.26
AVG Volume (30 Days)
104.5K
208.8K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$824,444,000.00
N/A
Revenue This Year
N/A
$88.12
Revenue Next Year
$4.73
$18.11
P/E Ratio
N/A
N/A
Revenue Growth
18.46
N/A
52 Week Low
$4.60
$10.75
52 Week High
$9.71
$73.06

Technical Indicators

Market Signals
Indicator
SRI
RNA
Relative Strength Index (RSI) 52.55 31.24
Support Level $7.26 N/A
Resistance Level $7.51 $14.30
Average True Range (ATR) 0.23 0.78
MACD 0.03 -0.30
Stochastic Oscillator 71.01 3.02

Price Performance

Historical Comparison
SRI
RNA

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company generates key revenue from the United States.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: